Belongia, E.A., Costa, J., Gareen, I.F., Grem, J.L., Inadomi, J.M., Kern, E.R., McHugh, J.A., Petersen, G.M., Rein, M.F., Sorrell, M.F., Strader, D.B. and Trotter, H.T. (2008) NIH Consensus Development Statement on Management of Hepatitis B. NIH Consens State Sci Statements, 25, 1-29.

has been cited by the following article:

• TITLE: 3 Case Reports of Fulminant Hepatitis A after Karballa Pilgrimage

  AUTHORS: Maryam Ansari Chaharsoughi, Hasan Salehi, Alireza Emami, Mohammadreza Yazdani, Mohammad Mahdi Salehi

  KEYWORDS: Fulminant Hepatitis, Deep Coma, Positive Hepatitis A Serology, Liver Enzyme Elevation

  JOURNAL NAME: Advances in Infectious Diseases, Vol.8 No.2, May 18, 2018

  ABSTRACT: Introduction: Fulminant hepatitis is a very rare disease that occurs as an acute liver failure within eight weeks of the onset of symptoms following hepatitis A in adults or in patients with a history of chronic hepatitis B or C [1]. Case presentation: There were three cases in this research. The first case was a self-employed male patient aged 26 years from Gaz Borkhar, admitted to Al-Zahral Hospital on January 1, 2016 for fever, chills and vomiting. The second patient was a 20-year-old male athlete from Lenjan and was hospitalized on May 3, 2016 for fever, chills, anorexia, yellowing of the skin, and low consciousness. The third case was a 20-year-old male employee from Isfahan who visited Al-Zahra Hospital for developing nausea, vomiting, and discolored urine, followed by icterus. Conclusion: all patients were young without any underlying disease. Although the disease had a very progressive course leading to coma, all cases fortunately survived through supportive measures and returned to their normal lives.